Related Experiment Video

Updated: Aug 21, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Evaluation of the interactions of common genetic mutations in stroke

Zoltán Szolnoki1

  • 1Department of Neurology and Neurophysiology, Pándy Kálmán County Hospital, Gyula, Hungary.

Methods in Molecular Medicine
|September 30, 2004
PubMed

Insights

Genetic factors significantly influence stroke risk. While single gene defects can cause stroke, combinations of common genetic variants like Factor V Leiden and MTHFR mutations can synergistically increase risk, impacting clinical outcomes.

Area of Science:

  • Neurology
  • Genetics
  • Cardiovascular Medicine

Background:

  • Stroke is a leading cause of death and disability globally.
  • Over 110 heritable disorders, 175 genetic loci, and 2050+ mutations are linked to stroke.
  • While single gene defects can cause stroke, common genetic factors often interact.

Purpose of the Study:

  • To discuss the evaluation of gene-gene and gene-environment interactions in stroke.
  • To interpret findings related to synergistic genetic effects on stroke risk.
  • To highlight the role of common genetic variants in stroke etiology.

Main Methods:

  • Review of known genetic factors predisposing to stroke.
  • Analysis of interactions between common genetic variants (e.g., Factor V Leiden, MTHFR, ApoE, ACE).
  • Discussion on evaluating the synergistic effects of these genetic factors.

Main Results:

  • Single gene defects can cause stroke (mendelian disorders).
  • Combinations of common genetic variants (Factor V Leiden, MTHFR 677TT, ApoE 4, ACE D/D) can exert synergistic effects.
  • These interactions can significantly impact clinical risk factors for stroke.

Conclusions:

  • Understanding genetic interactions is crucial for stroke risk assessment.
  • Synergistic effects of common genetic variants play a significant role in stroke etiology.
  • Evaluation and interpretation of these complex genetic interactions are essential for clinical practice.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...